Bibliography
- Alvar J, Vélez ID, Bern C, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:356-71
- Murray WH. Treatment of visceral leishmaniasis in 2004. Am J Trop Med Hyg 2004;71:787-94
- Chellat F, Merhi Y, Moreau A, Yahia L. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005;26:7260-75
- Yeeprae W, Kawakami S, Yamashita F, Hashida M. Effect of mannose density on mannose receptor-mediated cellular uptake of mannosylated o/w emulsions by macrophages. J Control Release 2006;114:193-201
- Wadhwa MS, Rice KG. Receptor mediated glycotargeting. J Drug Target 2003;11:255-68
- Irache JM, Salman HH, Gamazo C, Espuelas S. Mannose-targeted systems for the delivery of therapeutics. Expert Opin Drug Deliv 2008;6:703-24
- Vyas SP. Macrophage targeting and colloidal drug carriers. In: Vyas SP, Dixit VK, editors. Advances in liposomal research. CBS Publishers and Distributors, New Delhi; 2000. p. 98-120
- Bachhawat BK, Das PK, Ghosh PK. Preparation of glycosides bearing liposomes for targeting. In: Gregoriadis G, editor. Liposome technology. CRC Press, Boca Raton, FL; 1984. p. 117-38
- Garcon N, Gregoriadis G, Taylor M, Summerfield J. Mannose mediated targeted immunoadjuvant action of liposomes. Immunology 1988;64:743-8
- Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim) 2010;343:489-99
- Das R, Roy A, Dutta N, Majumder HK. Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis 2008;13:867-82
- Saleheen D, Ali SA, Ashfaq K, et al. Latent activity of curcumin against leishmaniasis in vitro. Biol Pharm Bull 2002;25:386-9
- Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or premalignant lesions. Anticancer Res 2001;21:2895-900
- Sharma RA, Euden SA, Platton SL, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847-54
- Tonnesen HH, Masson M, Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002;244:127-35
- Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807-18
- Rinaudo M. Chitin and chitosan: properties and applications. Prog Polym Sci 2006;31:603-32
- Chaubey P, Mishra B. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydr Polym 2014;101:1101-8
- Zhang J, Tang Q, Xu X, Li N. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery. Int J Pharm 2013;448:168-74
- Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 2005;22:27-105
- Leardi R. Experimental design in chemistry: a tutorial. Anal Chim Acta 2009;652:161-72
- Hibbert DB. Experimental design in chromatography: a tutorial review. J Chromatogr B Analyt Technol Biomed Life Sci 2012;910:2-13
- Bisht S, Feldmann G, Soni S, et al. Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology 2007;5:3
- Mukerjee A, Vishwanatha JK. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res 2009;29:3867-75
- Reddy LH, Murthy RSR. Pharmacokinetics and biodistribution studies of doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2004;148:161-6
- Gulyaev AE, Gelperina SE, Skidan IN, et al. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm Res 1999;16:1564-9
- Karki R, Subramanya G, Udupa N. Formulation and evaluation of coencapsulated rifampicin and isoniazid liposomes using different lipids. Acta Pharma Sci 2009;51:177-88
- Tiwari S, Chaturvedi AP, Tripathi YB, Mishra B. Macrophage specific targeting of isoniazid through mannosylated gelatin microspheres. AAPS PharmSci Tech 2011;12:900-8
- Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharmacol 2005;2:373-83
- Manandhar KD, Yadav TP, Prajapati VK, et al. Antileishmanial activity of nano-amphotericin B deoxycholate. J Antimicrob Chemother 2008;62:376-80
- Storm G, Belliot SO, Daemen T, Lasic DD. Surface modification of nanoparticles to oppose uptake by mononuclear phagocyte system. Adv Drug Deliv Rev 1995;17:31-48
- Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(,-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002;82:105-14
- Chakraborty S, Shukla D, Vuddanda PR, et al. Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles. Colloids Surf B Biointerfaces 2010;81:563-9
- Wisse E, Leeuw AM. Structural elements determining transport and exchange process in the liver. In: Davis SS, Illum L, McVie JG, Tomlinson E, editors. Microspheres and drug therapy, pharmaceutical, immunological and medical aspects. Elsevier, Amsterdam; 1984. p. 1-23
- Gonzalez-Mira E, Egea MA, Souto EB, et al. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Nanotechnology 2011;22:1-15
- Holzer M, Vogel V, Mäntele W, et al. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage. Eur J Pharm Biopharm 2009;72:428-37
- Chono S, Tanino T, Seki T, Morimoto K. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol 2007;59:75-80
- Douglas SJ, Illum L, Davis SS, Kreuter J. Particle size and size distribution of poly(butyl-2-cyanoacrylate) nanoparticles. J Colloid Interface Sci 1984;101:149-58
- Chiannilkulchai N, Ammoury N, Caillou B, et al. Hepatic tissue distribution of doxorubicin loaded nanoparticles after i.v. administration in reticulosarcoma M5076 metastases-bearing mice. Cancer Chemother Pharmacol 1990;26:122-6
- Kunwar A, Barik A, Mishra B, et al. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochem Biophys Acta 2008;1780:673-9
- Kim TH, Jiang HH, Youn YS, et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 2011;403:285-91
- Lankveld DP, Oomen AG, Krystek P, et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010;31(32):8350-61
- Anand P, Nair HB, Sung B, et al. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 2010;79:330-8
- Rittig MG, Bogdan C. Leishmania-host-cell interaction: complexities and alternative views. Parasitol Today 2000;16:292-7